3Rouzier R,Extra J M,Klijanienko J,et al.Incidence and prognostic significance of complete axillary downstaging after primary chemothera-py in breast cancer patients with T1 to T3 tumors and cytologically prov—en axillary metastatic lymph nodes[J].J Clin Oncol,2002,20(5):1304-1310.
4Proost J H,Eriksson L I,Mirakhur R K,et al.Urinary,biliary and faecal excretion of roeuronium in humans[J].Br J Anaesth,2000,85(5):717—723.
6Mannell A.Breast-conserving therapy in breast cancer patients-a 12-year experience[J].S Afr J Surg,2005,43(2):28-30.
7Veronesi U,Cascinelli N,Mariani L,et al.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J].N Engl J Med,2002,347(16):1227-1232.
8Deurloo E E,Peterse J L,Rutgers E J,et al.Additional breast lesions in patients eligible for breast-conserving therapy by MRI:impact on preoperative management and potential benefit of computerised analysis[J].Eur J Cancer,2005,41(10):1393-1401.
9Deurloo E E,Klein-Zeggelink W F,Teertstra H J,et al,Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy:complementary value for subgroups of patients[J].Eur Radiol,2006,16(3):692-701.
10Jakesz R,Samonigg H,Gnant M,et al.Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group[J].Ann Surg,2003,237(4):556-564.
